Genetic technologies – what are they and where might they take us?
14 November 2016 by Elizabeth Bohm, Senior Policy Adviser
Unless you have been actively avoiding the news, you have probably heard of CRISPR/Cas9, and how it could be a…
Elizabeth Bohm, Senior Policy Adviser
With a background in law, ethics and biology, I am interested in where these things meet. This spans a wide range of issues and I'll hopefully be able to represent some of these in my blog posts. Currently I'm looking at research integrity and scientific misconduct and public engagement in policy making so look out for more about these in the near future. Twitter: @ElizabethBohm
Feeding the world
11 August 2016 by Elizabeth Bohm, Senior Policy Adviser
The world faces a food security challenge to be able to produce more food sustainably. Previously on In Verba there…
We need to talk about gene editing
14 September 2015 by Elizabeth Bohm, Senior Policy Adviser
Chinese scientists brought the debate about the ethics of human gene editing into the spotlight in May this year when…
Beyond guidelines: where next for research integrity?
15 June 2015 by Elizabeth Bohm, Senior Policy Adviser
In the first week of June, the 4th World Conference on Research Integrity in Rio de Janeiro brought together participants…
We need to talk about culture
5 December 2014 by Elizabeth Bohm, Senior Policy Adviser
Yesterday, the Nuffield Council on Bioethics launched their report on research culture. The report examines aspects of research culture that…
Welcome to In Verba, the Royal Society's science policy blog.
Subscribe to RSS
Subscribe by emailPlease follow our community guidelines.